Navigation Links
Parents Make Donations to National Autism Association for Cutting-Edge Research
Date:9/25/2008

NIXA, Mo., Sept. 25 /PRNewswire-USNewswire/ -- The National Autism Association (NAA) has recently received generous donations totaling $30,000 for its Progress Research Fund from fellow parents within the autism community.

NAA expresses its sincere gratitude to Bruce and Kelly Vanicek for their $10,000 donation, as well as a contribution of $20,000 made by two other parents for a study being conducted by Gastroenterologist Andrew Wakefield. NAA research chair and founding board member Lyn Redwood commented, "Dr. Wakefield was one of the first to take the concerns of parents who reported that their children suffered with gastrointestinal problems seriously." She added, "We are honored to be able to support Dr. Wakefield as he continues to pursue the etiology and effective treatments for those diagnosed with autism."

NAA's main research focus is on the environmental component of autism spectrum disorders, an often times overlooked area of investigation. The goal of NAA's Progress Research Fund is to financially support studies that hold real promise for understanding mechanisms of injury and restoring health to those with an autism diagnosis.

The organization is currently funding research into the effects of mercury exposure in the brains of infant primates. The primary investigator is Dr. Thomas Burbacher, a University of Washington researcher whose earlier work found that exposure to Thimerosal, the ethylmercury-based vaccine preservative, resulted in inorganic mercury deposits in the brain that were twice the amount of those following exposure to equal amounts of methyl mercury, the type commonly found in fish. Previous research has documented that inorganic mercury is associated with a neuro-inflammatory process, recently documented to also occur in the brains of children diagnosed with autism. Inorganic mercury has no discernable half-life and, once trapped in the brain, continues to damage brain cells.

To donate to NAA's Progress Research Fund, please visit http://www.nationalautism.org.

CONTACT: Lyn Redwood (Atlanta, GA) 404-932-1786, or Laura Bono (Durham, NC) 919-403-9443, both of the National Autism Association


'/>"/>
SOURCE National Autism Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
2. An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R)
3. Survey Shows Parents Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
11. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of the ... is the creation of published author, John Allred, a passionate leader of ministry to ... who has traveled and ministered on four continents. , “It is my hope and ...
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
Breaking Medicine News(10 mins):